FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma
The Food and Drug Administration (FDA) granted accelerated approval to the combination of nivolumab and…
Browsing: Kidney Cancer
Chemotherapy after surgery halves risk of rare kidney cancer coming back
Chemotherapy halves the risk of a rare form of kidney cancer coming back after surgery,…
Clinical trial exposes deadly kidney cancer’s Achilles’ heel
An experimental drug already shown to be safe and help some patients with clear cell…
ASCO GU 2020: Nivolumab plus ipilimumab benefit for advanced kidney cancer
Updated results have been released from the Phase 3 CheckMate -214 study evaluating the combination…
Cutting off kidney cancer at its roots
Scientists at the Max Delbrück Center for Molecular Medicine in Berlin, Germany, (MDC) have discovered…
Novel Targeted Drug Shows Promise in Advanced Kidney Cancer
Scientists report promising activity of a novel drug that targets a key molecular driver of…
B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells…
Kidney cancer study uncovers new subtypes and clues to better diagnosis and treatment
The researchers used the most advanced genomic and proteomic technologies available to tease out their…
Study examines kidney injury in patients taking immunotherapy cancer medications
A new study indicates that kidney damage is fairly common in patients who take immunotherapy…
ANZUP Trial’s TheraP and UNISoN reach recruitment
By Nicole Tankard, ANZUP ANZUP, the Australian and New Zealand Urogenital and Prostate cancer trials…